Clafen (Cyclophosphamide) Chemical Structure
Potent anticancer agent that blocks DNA synthesis.
Nelarabine(Arranon) performes growth inhibitory activity (IC50= 1.61 μM) against MOLT-4 cells
A glycopeptide antibiotic produced by the bacterium Streptomyces verticillus.
This drug performed growth inhibitory activity in IGROV1 and OAW42 cells(IC50 of 25 and 30 mg/l,respectively).
Clofarabine inhibits the enzymatic activities of ribonucleotide reductase (IC50 = 65 nM) and DNA polymerase
Oxaliplatin (Eloxatin) is a 1,2-diaminocyclohexane (DACH) carrier ligand-based groups of platinum antitumor agent with IC50 of median 1.3, 6.2 and 1.5 mM for SW480 DLD1, HT29, respectively.
CCT239065 is a novel, selective, and efficacious nanomolar pyridopyrazinone V600E BRAF and LCK inhibitor with IC50 of 13 nM and 6 nM, respectively.
NSC-207895 (XI-006) is a derivative of nitrobenzofuroxan and an anticancer agent with an EC50 of 1 μM.
CX-5461 is a potent small-molecule rRNA synthesis inhibitor with an IC50 of 0.11 μM.
ABT-888 (Veliparib) is a potent poly (ADP-ribose) polymerase (PARP) inhibitor of PARP-1 and PARP-2 with Ki of 5.2 nM and 2.9 nM, respectively.
Cyclophosphamide is a synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. In the liver, cyclophosphamide is converted to the active metabolites aldophosphamide and phosphoramide mustard, which bind to DNA, thereby inhibiting DNA replication and initiating cell death. [1]
Cyclophosphamide is given as a treatment for many types of cancer, among them lymphomas, ovary, breast, and bladder; and chronic lymphocytic leukaemia. [2]
This agent inhibited cell proliferation of NCI-H727 with IC50 at 9.3 nM. [3]
| Molecular Weight (WM): | 261.09 |
|---|---|
| Formula: | C7H15Cl2N2O2P |
| CAS No.: | 50-18-0 |
| Synonyms: |
Endoxan, Cytoxan, Neosar, Procytox, Revimmune, Cytophosphane
|
| Dissolve in (25°C): | DMSO ≥52mg/mL |
| Water ≥43mg/mL | |
| Ethanol ≥52mg/mL | |
| Storage: | 2 years-20°CPowder |
| 1 week-4°Cin DMSO | |
| 1 month-80°in DMSO |
A collection of 864 bioactive compounds
A collection of 481 inhibitors
A collection of 194 kinase inhibitors
A collection of 85 tyrosine kinase inhibitors.
A collection of 426 FDA approved drugs
A collection of 139 natural products
A collection of 40 chemotherapeutic agents
A unique collection of 17 small molecule modulators
A unique collection of 47 small molecule inhibitors
A unique collection of 63 GPCR small molecules
Keywords:buy Clafen (Cyclophosphamide) | Clafen (Cyclophosphamide) supplier | purchase Clafen (Cyclophosphamide) | Clafen (Cyclophosphamide) cost | Clafen (Cyclophosphamide) manufacturer | order Clafen (Cyclophosphamide) | Clafen (Cyclophosphamide) distributor